You are here

Penultimate Draft Manuscript Review - Standard

All manuscripts using unpublished CHS data require review by CHS prior to submission to journal.

The Publications & Presentations Committee coordinates the distributed review of manuscripts. Your penultimate draft manuscript should be sufficiently developed for subsequent submission to a journal, although it will undergo further internal review by the Steering Committee and (if applicable) NHLBI, prior to release for journal submission.

Penultimate drafts may be submitted at any time using the online submission form on the internal CHS website. 

Average duration of review: 3-4 weeks

Criteria for review: see CHS Reviewer Guidelines

Penultimate Draft Manuscript Review Process (Standard):

  • P&P Review: When all members of the writing group have approved the penultimate draft, it may be submitted online for review.

The P&P Coordinator will distribute your completed manuscript as soon as it is received to a group of 3-4 reviewers chosen by area of expertise; the list of reviewers for P&P consists of all participating CHS Investigators and Collaborators. Upon completion of review, comments are forwarded to the P&P Chair for a verdict. If the paper is approved, comments will be sent anonymously to the Writing Group in a formal approval memo with an invitation to respond or revise prior to Steering Committee review (optional). Papers that are not approved must be revised; revisions must be accompanied by a memo outlining what has changed.
 

  • Steering Committee & NHLBI Review: Upon P&P approval, the manuscript will be forwarded to the Steering Committee for review, along with the anonymous comments from the P&P reviewers. If any author on the paper is an employee of the NHLBI, the paper will also be forwarded to the NHLBI Project Office for simultaneous review. If the draft is approved, or approved with modifications, approval notification and comments, if any, will be communicated to the writing group chair. A draft approved with "required modifications" must incorporate the changes required by the reviewer(s); if the writing group disagrees with the requested changes, the chair must submit a written rebuttal. A copy of the revised manuscript must be submitted online. The NHLBI Project Office (if applicable), will contact the writing group chair directly regarding outcome of the review.
     
  • Journal submission: Once CHS and NHLBI (if applicable) have approved the manuscript, you may proceed with journal submission. Please notify us via your online record with the name of the journal to which you are sending your CHS manuscript.
     
  • Pubmed Central: Upon journal acceptance it is required that you submit your paper to Pubmed Central per the Public Access Policy at the following website: http://publicaccess.nih.gov/. Please review these guidelines before you sign a publication agreement or similar copyright transfer agreement, and make sure that the agreement allows your CHS paper to be submitted to NIH in accordance with the posted guidelines
     
  • CHS Notification: Please update your online record whenever the status of your submission changes. 
     
  • Modifications after submission: It is expected that journals will request additional modifications; unless such modifications will significantly impact the previously approved analyses, no further CHS or NHLBI review is necessary.

 

Related Links

Expedited Penultimate Draft Manuscript Review Process
CHS & NHLBI Acknowledgment Guidelines
P&P Reviewer Guidelines
CHS Verification Policy
NIH Public Access Policy – PubMed Central